Publication
Article
The American Journal of Managed Care
The content in this supplement to is based on a roundtable meeting and discussion with a multidisciplinary panel of clinical experts, managed care medical and pharmacy directors, Alzheimer’s disease (AD) advocates, and health economists.
This supplement describes the growing burden of AD, reviews pharmacologic treatment options for AD, and discusses trends and best practices in the management of AD, including the role of combination therapy. It also describes the economic burden of AD and reviews the economic implications of effective management of AD.
Faculty
Alireza Atri, MD, PhD
Associate Director, Clinical Programs
Geriatric Research, Education, and Clinical Center (GRECC)
ENRM VA Bedford Medical Center
Bedford, Massachusetts
Assistant in Neurology
Memory Disorders Unit & Massachusetts Alzheimer’s Disease
Research Center
Department of Neurology
Massachusetts General Hospital
Harvard Medical School
Boston, Massachusetts
Oscar L. Lopez, MD
Professor of Neurology and Psychiatry
University of Pittsburgh
Pittsburgh, Pennsylvania
Richard G. Stefanacci, DO, MGH, MBA, AGSF, CMD
Associate Professor
Health Policy
University of the Sciences in Philadelphia
Philadelphia, Pennsylvania
Chief Medical Director
The Access Group
Berkeley Heights, New Jersey
Faculty Disclosures
These faculty report relationships with the following organizations:
Alireza Atri, MD, PhD
Consultant/advisory board:
Forest Laboratories, Inc, Lundbeck, Merz
Grants:
Forest Research Institute
Lecturer:
Lundbeck, Merz
Oscar L. Lopez, MD
Consultant/advisory board:
Johnson & Johnson, Lundbeck
Richard G. Stefanacci, DO, MGH, MBA, AGSF, CMD
Lecturer:
Eisai, Forest Laboratories, Inc, Pfizer
The American Journal of ManagedCare
Signed disclosures are on file at the office of , Plainsboro, New Jersey.
This supplement was supported by Forest Laboratories, Inc.